Tag: Plavix
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT
Generic Clopidogrel Noninferior to Plavix in Seniors With ACS
Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization
AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD
No better for primary efficacy composite end point of cardiovascular death, myocardial infarction, stroke
Individual Short-Term Responses to Antiplatelet Therapy Vary
Variability within individuals from pre-discharge to one week after discharge, but not thereafter
